-
Novartis Pharmaceuticals Corporation v. Lupin Inc. DC
- 1:21-cv-01105
- D. Del.
- Judge: Maryellen Noreika
- Filed: 07/29/2021
- Closed: 12/05/2023
- Latest Docket Entry: 12/08/2023
- PACER
- Docket updated daily
1
Plaintiff
1
Defendant
1
Accused
Product
1
Patent-in-Suit
860
Days in
Litigation
-
Novartis Pharmaceuticals Corporation v. Lupin Inc. DC
- 1:21-cv-01105
- D. Del.
- Judge: Maryellen Noreika
- Filed: 07/29/2021
- Closed: 12/05/2023
- Latest Docket Entry: 12/08/2023
- PACER
- Docket updated daily
Cause of Action
Infringement
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
Lupin Inc.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic version of RYDAPT®(Midostaurin) Capsules, 25 mg | US 8,575,146 B2 | All Asserted Claims |
Infringement
Entry 93
|
